137 related articles for article (PubMed ID: 18466686)
1. New aspects in the treatment of asthma: targeted therapy.
Wang ZL
Chin Med J (Engl); 2008 Apr; 121(7):640-8. PubMed ID: 18466686
[No Abstract] [Full Text] [Related]
2. New therapies for asthma: where next?
Robinson DS
Pediatr Pulmonol; 2003 Nov; 36(5):369-75. PubMed ID: 14520718
[No Abstract] [Full Text] [Related]
3. New treatments for asthma: current and future aspects.
Hansel TT
Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S3-6. PubMed ID: 11385813
[TBL] [Abstract][Full Text] [Related]
4. Biologic targeted therapy in allergic asthma.
Bice JB; Leechawengwongs E; Montanaro A
Ann Allergy Asthma Immunol; 2014 Feb; 112(2):108-15. PubMed ID: 24468249
[TBL] [Abstract][Full Text] [Related]
5. Novel monoclonal treatments in severe asthma.
Meteran H; Meteran H; Porsbjerg C; Backer V
J Asthma; 2017 Dec; 54(10):991-1011. PubMed ID: 28287273
[TBL] [Abstract][Full Text] [Related]
6. [IgE regulation in asthma pathogenesis and development of a monoclonal anti-IgE antibody for the treatment of allergic asthma].
Wang G; Wang ZL
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jul; 26(7):427-30. PubMed ID: 14649229
[No Abstract] [Full Text] [Related]
7. An update on biologic-based therapy in asthma.
Walsh GM
Immunotherapy; 2013 Nov; 5(11):1255-64. PubMed ID: 24188679
[TBL] [Abstract][Full Text] [Related]
8. Anti-IgE and other new immunomodulation-based therapies for allergic asthma.
Jonkers RE; van der Zee JS
Neth J Med; 2005 Apr; 63(4):121-8. PubMed ID: 15869039
[TBL] [Abstract][Full Text] [Related]
9. [Anti-IgE therapy in persistent allergic asthma].
Skiepko R; Zietkowski Z; Tomasiak-Łozowska MM; Bodzenta-Łukaszyk A
Przegl Lek; 2009; 66(3):141-4. PubMed ID: 19689039
[TBL] [Abstract][Full Text] [Related]
10. Anti-IgE therapy.
Brownell J; Casale TB
Immunol Allergy Clin North Am; 2004 Nov; 24(4):551-68, v. PubMed ID: 15474858
[TBL] [Abstract][Full Text] [Related]
11. Omalizumab (Xolair): an anti-IgE antibody for asthma.
Med Lett Drugs Ther; 2003 Aug; 45(1163):67-8. PubMed ID: 12915804
[No Abstract] [Full Text] [Related]
12. Omalizumab treatment in a child with severe asthma and multiple steroid-induced morbidities.
Rizk C; Ring A; Santucci S; MacLusky I; Karsh J; Yang WH
Ann Allergy Asthma Immunol; 2012 Sep; 109(3):222-3. PubMed ID: 22920081
[No Abstract] [Full Text] [Related]
13. Anti-IgE or Anti-IL5: That Is the Question.
Israel E; Panettieri RA
J Allergy Clin Immunol Pract; 2018; 6(3):782-784. PubMed ID: 29150253
[No Abstract] [Full Text] [Related]
14. Novel molecular therapy.
Wildhaber JH
Paediatr Respir Rev; 2006; 7 Suppl 1():S104-5. PubMed ID: 16798525
[TBL] [Abstract][Full Text] [Related]
15. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
Holgate ST; Djukanović R; Casale T; Bousquet J
Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
[TBL] [Abstract][Full Text] [Related]
16. Cytokine modulators as novel therapies for asthma.
Barnes PJ
Annu Rev Pharmacol Toxicol; 2002; 42():81-98. PubMed ID: 11807165
[TBL] [Abstract][Full Text] [Related]
17. [Anti-IgE therapy].
Chazan R
Pneumonol Alergol Pol; 2002; 70 Suppl 1():76-81. PubMed ID: 12518645
[No Abstract] [Full Text] [Related]
18. Pediatric Asthma--do we need more innovation for treatment?
Riedler J
Pediatr Allergy Immunol; 2014 Feb; 25(1):19-20. PubMed ID: 24588482
[No Abstract] [Full Text] [Related]
19. [Biotherapies for the treatment of asthma: are they the treatment of the future?].
Tonnel AB; Denis G; Lelong J
Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S44-10S48. PubMed ID: 17127963
[No Abstract] [Full Text] [Related]
20. Monoclonal antibodies and other biologic agents in the treatment of asthma.
Long AA
MAbs; 2009; 1(3):237-46. PubMed ID: 20065638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
